75A50122D00021-75A50126F61002
Delivery Order
Overview
Government Description
Rtor BIO-AMT-2312: assessment of the therapeutic potential of chloroquine and oseltamivir in two (2) lethal models of influenza a H5N1
Awarding / Funding Agency
Place of Performance
Albuquerque, NM 87108 United States
Pricing
Cost Plus Fixed Fee
Set Aside
None
Extent Competed
Full And Open Competition
Est. Average FTE
11
Related Opportunity
(Parent Award)
RTORBIOAMT2312
Analysis Notes
Subcontracting Plan This Delivery Order has an Individual Subcontract Plan. The Department of Health and Human Services has an overall small business subcontracting goal of 32%
Lovelace Biomedical Research Institute was awarded
Delivery Order 75A50126F61002 (75A501-26-F-61002)
worth up to $3,723,027
by the HHS Office of the Assistant Secretary for Preparedness and Response
in August 2026.
The contract
has a duration of 1 year 8 months and
was awarded
through solicitation RTORBIOAMT2312
full & open
with
NAICS 541714 and
PSC AN13
via direct negotiation acquisition procedures.
This contract was awarded through vehicle BARDA Biological Animal Model And MCM Development.
Status
(Open)
Last Modified 8/21/26
Period of Performance
8/26/26
Start Date
4/25/28
Current End Date
4/25/28
Potential End Date
Obligations
$3.7M
Total Obligated
$3.7M
Current Award
$3.7M
Potential Award
Award Hierarchy
Indefinite Delivery Contract
Delivery Order
75A50122D00021-75A50126F61002
Subcontracts
Activity Timeline
People
Suggested agency contacts for 75A50122D00021-75A50126F61002
Competition
Number of Bidders
Not Applicable
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Individual Subcontract Plan
Cost Accounting Standards
Yes
Business Size Determination
Large Business
Awardee UEI
MBT9RXJJ7428
Awardee CAGE
3MMH4
Agency Detail
Awarding Office
75A501 BARDA - ASPR / DAAPPO / BARDA DCMA
Funding Office
75A501
Created By
danielle.hinton@hhs.gov
Last Modified By
hhstsullivan
Approved By
hhstsullivan
Legislative
Legislative Mandates
Clinger-Cohen Act Compliant
Performance District
NM-01
Senators
Martin Heinrich
Ben Luján
Ben Luján
Representative
Melanie Stansbury
Modified: 8/21/26